Meera Mohan Selected Research

Meera Mohan Research Topics

33	Multiple Myeloma 04/2024 - 12/2016
4	Infections 03/2024 - 01/2022
4	Bacteremia 06/2020 - 04/2019
3	Neoplasms (Cancer) 01/2023 - 01/2020
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2024 - 01/2022
1	Thrombocytopenia (Thrombopenia) 02/2024
1	Anemia 02/2024
1	Bronchiolitis Obliterans Syndrome 01/2024
1	Agammaglobulinemia (Hypogammaglobulinemia) 08/2023
1	Lymphopenia (Lymphocytopenia) 08/2023
1	Bites and Stings (Sting) 11/2022
1	Residual Neoplasm 01/2022
1	Cardiotoxicity 11/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021
1	Hypercalcemia (Milk Alkali Syndrome) 10/2020
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2020
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 06/2020
1	Hodgkin Disease (Hodgkin's Disease) 01/2020
1	Dysarthria (Spastic Dysarthria) 01/2020
1	Deglutition Disorders (Dysphagia) 01/2020
1	Urinary Tract Infections (Urinary Tract Infection) 04/2019
1	Cross Infection (Nosocomial Infection) 04/2019
1	Renal Insufficiency (Renal Failure) 01/2017
1	Fever (Fevers) 12/2016
1	Weight Loss (Weight Reduction) 12/2016
1	Plasmacytoma 03/2016

7	Monoclonal AntibodiesIBA 01/2023 - 01/2020
5	daratumumabIBA 06/2023 - 01/2020
4	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 03/2024 - 01/2023
4	Chimeric Antigen ReceptorsIBA 02/2024 - 01/2021
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023 - 12/2021
3	Vancomycin FDA LinkGeneric 06/2020 - 04/2019
2	B-Cell Maturation AntigenIBA 03/2024 - 01/2022
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2024 - 12/2021
2	Bispecific AntibodiesIBA 08/2023 - 01/2021
2	Daptomycin FDA Link 06/2020 - 02/2020
2	Bortezomib (Velcade)FDA Link 01/2019 - 01/2017
1	Intravenous Immunoglobulins (IVIG)FDA Link 03/2024
1	Hemoglobins (Hemoglobin)IBA 02/2024
1	Calcineurin InhibitorsIBA 01/2024
1	Methotrexate (Mexate)FDA LinkGeneric 01/2024
1	Adenosine Monophosphate (AMP)IBA 01/2024
1	Proteasome InhibitorsIBA 06/2023
1	Immunomodulating AgentsIBA 06/2023
1	pomalidomideIBA 01/2023
1	Lenalidomide (CC 5013)FDA Link 01/2023
1	mRNA VaccinesIBA 11/2022
1	carfilzomibIBA 12/2021
1	ADP-ribosyl Cyclase 1IBA 11/2021
1	pembrolizumabIBA 10/2021
1	AntibodiesIBA 09/2021
1	Diphosphonates (Bisphosphonates)IBA 10/2020
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 10/2020
1	NivolumabIBA 01/2020

17	Therapeutics 04/2024 - 03/2016
7	Stem Cell Transplantation 01/2023 - 04/2019
4	Drug Therapy (Chemotherapy) 01/2023 - 04/2019
3	Cell Transplantation 01/2024 - 11/2022
3	Immunotherapy 01/2022 - 01/2021
2	Homologous Transplantation 01/2024 - 12/2023
2	Transplantation 01/2022 - 01/2021
1	Hematopoietic Stem Cell Transplantation 04/2024
1	Retreatment 06/2023
1	Aftercare (After-Treatment) 01/2022
1	Salvage Therapy 11/2021
1	Precision Medicine 11/2021
1	Maintenance Chemotherapy 12/2016